Last reviewed · How we verify

UC-MSC and Secretome

PT. Prodia Stem Cell Indonesia · Phase 1 active Biologic

UC-MSC and Secretome is a Biologic drug developed by PT. Prodia Stem Cell Indonesia. It is currently in Phase 1 development. Also known as: Umbilical Cord- Mesenchymal Stem Cell (UC-MSCS) and Secretome.

At a glance

Generic nameUC-MSC and Secretome
Also known asUmbilical Cord- Mesenchymal Stem Cell (UC-MSCS) and Secretome
SponsorPT. Prodia Stem Cell Indonesia
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about UC-MSC and Secretome

What is UC-MSC and Secretome?

UC-MSC and Secretome is a Biologic drug developed by PT. Prodia Stem Cell Indonesia.

Who makes UC-MSC and Secretome?

UC-MSC and Secretome is developed by PT. Prodia Stem Cell Indonesia (see full PT. Prodia Stem Cell Indonesia pipeline at /company/pt-prodia-stem-cell-indonesia).

Is UC-MSC and Secretome also known as anything else?

UC-MSC and Secretome is also known as Umbilical Cord- Mesenchymal Stem Cell (UC-MSCS) and Secretome.

What development phase is UC-MSC and Secretome in?

UC-MSC and Secretome is in Phase 1.

Related